Company / Gross Profit
Apyx Medical Corp Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$33.0M
FY2025
5-year range
$17.5M / $33.0M
FY2021-FY2025
Trend
+12.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has fluctuated over the past 10 years, ranging from $5M in FY2018 to $33M in FY2025.
Based on SEC 10-K filings.
$33M in FY2025 with a 5-year CAGR of +11.6%.
Improved from $29M to $33M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +4.3%
- 5-Year CAGR
- +11.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +11.6%, indicating consistent growth.
- In FY2025, gross profit increased 12.5% year-over-year.
- Lowest gross profit in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $33.0M | +12.5% |
| FY2024 | $29.4M | +0.8% |
| FY2023 | $29.1M | +0.0% |
| FY2022 | $29.1M | +66.4% |
| FY2021 | $17.5M | -8.3% |
| FY2020 | $19.1M | +174.4% |
| FY2019 | $7.0M | +36.0% |
| FY2018 | $5.1M | -59.3% |
| FY2017 | $12.6M | +39.6% |
| FY2016 | $9.0M | -2.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026